You have 9 free searches left this month | to do more

Bosutinib

Bosutinib is a drug used to treat Chronic Myeloid Leukemia, Healthy, Breast Cancer, and other conditions. Bosutinib is being actively studied in 17 studies and prior, has been studied in 17.

Top SponsorsTop SitesTop Investigators
PfizerPfizer Investigational SiteHaruhisa Inoue
Wyeth is now a wholly owned subsidiary of PfizerM D Anderson Cancer CenterNagla Abdel Karim
M.D. Anderson Cancer CenterRoswell Park Cancer InstituteSheldon Jordan
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Not yet recruiting
  • Healthy Participants
  • Bosutinib capsule
  • Bosutinib
  • New Haven, Connecticut
    Pfizer Clinical Research Unit
2021-11-08
Nov 8, 2021
P
Recruiting
  • Chronic Myelogenous Leukemia
  • Bosutinib
  • Shibuya-ku, Japan
    (unnamed)
2020-12-29
Dec 29, 2020
N
Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
2021-07-31
Jul 31, 2021
K
Recruiting
  • Amyotrophic Lateral Sclerosis
  • Bosutinib
  • Kyoto, Japan
  • +3 more
2021-02-03
Feb 3, 2021
M
Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia (CML)
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2020-11-17
Nov 17, 2020
S
Recruiting
  • Chronic Myeloid Leukemia
  • Aalborg, Denmark
  • +17 more
2021-03-31
Mar 31, 2021
G
Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center
2021-05-26
May 26, 2021
M
Terminated
  • Blasts Under 15 Percent of Bone Marrow Nucleated Cells
  • +4 more
  • Bosutinib
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
2020-04-22
Apr 22, 2020
M
Recruiting
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +6 more
  • Bosutinib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2020-06-25
Jun 25, 2020
P
Completed
  • Chronic Myeloblastic Leukaemia
  • Bosutinib
  • Gran Canaria, Spain
  • +12 more
2020-04-28
Apr 28, 2020
N
Enrolling by invitation
  • Mild Cognitive Impairment
  • Dementia
  • bosutinib
  • Santa Monica, California
    Neurological Associates of West LA
2021-02-25
Feb 25, 2021
N
Not yet recruiting
  • Chronic Myelogenous Leukemia
  • Asciminib single agent
  • +6 more
  • (no location specified)
2021-11-25
Nov 25, 2021
N
Active, not recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Moscow, Russian Federation
    National Research Center for Hematology
2020-10-01
Oct 1, 2020
P
Completed
  • Chronic Myeloid Leukaemia
  • Bosutinib
  • Liverpool, Merseyside, United Kingdom
  • +2 more
2019-05-01
May 1, 2019
U
Completed
  • Leukemia
  • +3 more
  • Bosutinib
  • +2 more
  • Monza, Italy/MB, Italy
  • +1 more
2020-11-03
Nov 3, 2020
U
Active, not recruiting
  • CML, Chronic Phase
  • +4 more
  • Bosutinib
  • +3 more
  • Chapel Hill, North Carolina
    UNC Hospital
2021-08-27
Aug 27, 2021
C
Recruiting
  • Philadelphia Chromosome Positive CML
  • +3 more
  • Bosutinib
  • Birmingham, Alabama
  • +39 more
2021-12-17
Dec 17, 2021
G
Active, not recruiting
  • Chronic Myeloid Leukemia
  • Bosutinib
  • Alessandria, Italy
  • +44 more
2022-01-04
Jan 4, 2022
C
Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
2021-11-08
Nov 8, 2021
N
Recruiting
  • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
  • Greenwood Village, Colorado
  • +28 more
2022-01-11
Jan 11, 2022
N
Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Chicago, Illinois
  • +86 more
2021-11-16
Nov 16, 2021
P
Completed
  • Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive
  • Anaheim, California
  • +188 more
2021-04-16
Apr 16, 2021